Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank68
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-0.29%
↓ 103% vs avg
Percentile
P68
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
11.37%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -0.29% |
| Q3 2025 | -19.45% |
| Q2 2025 | -119.28% |
| Q1 2025 | 668.39% |
| Q4 2024 | -7.30% |
| Q3 2024 | -23.68% |
| Q2 2024 | 28.86% |
| Q1 2024 | -18.97% |
| Q4 2023 | -19.62% |
| Q3 2023 | 20.82% |
| Q2 2023 | -2.08% |
| Q1 2023 | 4.55% |
| Q4 2022 | -1.44% |
| Q3 2022 | -10.68% |
| Q2 2022 | -161.33% |
| Q1 2022 | 299.85% |
| Q4 2021 | -10.73% |
| Q3 2021 | 7.26% |
| Q2 2021 | 21.38% |
| Q1 2021 | -84.21% |
| Q4 2020 | -0.53% |
| Q3 2020 | -12.72% |
| Q2 2020 | 10.44% |
| Q1 2020 | -5.59% |
| Q4 2019 | -26.75% |
| Q3 2019 | -28.28% |
| Q2 2019 | 3.95% |
| Q1 2019 | -85.83% |
| Q4 2018 | -15.59% |
| Q3 2018 | -25.71% |
| Q2 2018 | -21.62% |
| Q1 2018 | 0.00% |